Conference Details

16th Biosimilars Congregation 2021 (Virtual Conference)

  • Health and Medicine
  • Life Science
  • Conference
  • Dec 9, 2021 - Dec 9, 2021
  • Online Conference
  • Online Conference, India
  • Rating:
Paper Submission Date
11-22-21
Registration Date
12-08-21
Acceptance Notification Date
12-08-21

Description

16th Biosimilars Congregation 2021

“Uniting industry leaders to analyse advanced commercial developments & identify successful management strategies of Biosimilars”

09th December 2021, Virtual Conference (Time Zone – IST)

Virtue Insight is delighted to invite you to attend the 16th Biosimilars Congregation 2021 conference, to be held on 09th December 2021(Virtual Conference). 16th Biosimilars Congregation 2021 brings together scientists, researchers and CROs from around the world. At 16th Biosimilars Congregation 2021 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference would be your single best opportunity to reach the largest assemblage of participants from the biologics and biosimilars community

DELEGATE REGISTRATION:

E-mail - kavitha@virtueinsight.co.in or Call M: +91 9361957193 or T: +91 44 24762472

Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer. 

  • Early Bird Price (Valid Till 12th Nov 2021) – (INR 6,000 + GST (18%) per delegate)
  • Standard Price (Valid From 13th Nov 2021) – (INR 8,000 + GST (18%) per delegate)

Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in


List of Main Topics

  • • Recent trends and new normal in Biosimilars - How to excel with this? • Development challenges on the biosimilars products for companies? What are the remedies? • Pharmacovigilance and risk management of biosimilars. • Successful business models and dealing with every ambiguity mAbs - Could be a game changer in India • Impact of the pandemic - affecting the biosimilar markets • Ways for smart handling of market access
  • sustainable pricing and reimbursement of biosimilars in the market. • Challenges and changes interchangeability • How does strategic planning really help to grow market opportunities? • Market barriers for biosimilar approval in India market. • Future opportunities for product development • Risk of adverse effects related to new drug development. How to overcome that? • Newer versions of generic drugs truly increase the value of the market? • How to speed up the process of development and reduce costs of production? • Regulators view on interchangeability and switching biosimilars. • How to minimise the rejection of biosimilar applications while evaluating regulatory bodies? • Next 5 years in the field of biosimilars regulations

Speakers

ARANI CHATTERJEE


Submission Instructions

  • Recent trends and new normal in Biosimilars - How to excel with this?
  • Development challenges on the biosimilars products for companies? What are the remedies?
  • Pharmacovigilance and risk management of biosimilars.
  • Successful business models and dealing with every ambiguity mAbs - Could be a game changer in India
  • Impact of the pandemic - affecting the biosimilar markets
  • Ways for smart handling of market access, sustainable pricing and reimbursement of biosimilars in the market.
  • Challenges and changes interchangeability
  • How does strategic planning really help to grow market opportunities?
  • Market barriers for biosimilar approval in India market.
  • Future opportunities for product development
  • Risk of adverse effects related to new drug development. How to overcome that?
  • Newer versions of generic drugs truly increase the value of the market?
  • How to speed up the process of development and reduce costs of production?
  • Regulators view on interchangeability and switching biosimilars.
  • How to minimise the rejection of biosimilar applications while evaluating regulatory bodies?
  • Next 5 years in the field of biosimilars regulations


Submission Dates

Abstract Date
11-22-21

Registration Fee and Instructions

DELEGATE REGISTRATION:

E-mail - kavitha@virtueinsight.co.in or Call M: +91 9361957193 or T: +91 44 24762472

Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer. 

  • Early Bird Price (Valid Till 12th Nov 2021) – (INR 6,000 + GST (18%) per delegate)
  • Standard Price (Valid From 13th Nov 2021) – (INR 8,000 + GST (18%) per delegate)

Conference Sponsor, Exhibition Stall & Paid Speaker Slot - Please email your interest and queries to kavitha@virtueinsight.co.in